- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01312649
Feeling of Being in Control of One's Own Action
December 15, 2025 updated by: University Hospital, Strasbourg, France
Feeling of Being in Control of One's Own Action: Which Mechanisms in Healthy Volunteers and in Mental Diseases
The investigators aim is to understand the cognitive mechanisms that contribute to the emergence of delusions of control (the belief that one's own actions or thoughts are controlled by an external force).
These symptoms are mainly encountered in patients with schizophrenia, and the investigators will distinguish patients with schizophrenia with or without this symptom together with patients with bipolar disorder.
Based on the investigators previous studies, this project will help to determine the role of two elementary mechanisms in the ability to feel in control of voluntary actions: (1) the processing of the sensory consequences of action, and (2) the ability to build mental representations for sequenced actions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
198
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Strasbourg, France
- Pôle de Psychiatrie - Hôpital civil
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients with schizophrenia or bipolar disorders (criteria DSM IV) or healthy controls matched with patients on age, sex and education level
- 18-55 years old
Exclusion Criteria:
- Past history affecting CNS
- Invalidating sensory disorders
- Intake of psychotropic drugs, except for patients
- Intake of benzodiazepines
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1
Healthy volunteers
|
|
|
Experimental: Arm 2
Schizophrenia with history of delusions of control
|
|
|
Experimental: Arm 3
Schizophrenia without history of delusions of control
|
|
|
Experimental: Arm 4
Bipolar disorders
|
|
|
Active Comparator: Arm 5
Matched healthy controls
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Anne GIERSCH, MD, Hopitaux universitaires de Strasbourg
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2011
Primary Completion (Actual)
June 15, 2017
Study Completion (Actual)
July 4, 2017
Study Registration Dates
First Submitted
March 1, 2011
First Submitted That Met QC Criteria
March 10, 2011
First Posted (Estimated)
March 11, 2011
Study Record Updates
Last Update Posted (Estimated)
December 16, 2025
Last Update Submitted That Met QC Criteria
December 15, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4880
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Experimental psychology methods (computer tests)
-
Fundacin Biomedica Galicia SurUniversity of Vigo; Galician South Health Research InstituteNot yet recruitingCOVID-19 | Fatigue | Cognitive Dysfunction | COVID-19 Recurrent | SARS CoV 2 Infection | Distress Respiratory SyndromeSpain
-
UNC Lineberger Comprehensive Cancer CenterCompletedObesity | Cancer | Physical Activity | Mental Health | Cancer SurvivorshipUnited States
-
Pontificia Universidad Catolica de ValparaisoCompleted
-
Centre Hospitalier EsquirolCompleted
-
University Hospital, LilleRecruiting
-
University of MiamiNational Eye Institute (NEI)CompletedGlaucoma | Macular Degeneration | Retinal Degeneration | Optic Neuropathy | Glaucoma Suspect | Visual Pathway DisorderUnited States
-
Giresun UniversityCompleted
-
Rennes University HospitalCompleted
-
Massachusetts General HospitalRecruiting
-
Grupo LusófonaActive, not recruiting